| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Mouse TACI/TNFRSF13B Fc Chimera Protein, CF |
|---|
| Description | Purity >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 47 kDa, reducing conditions. MW (theoretical): 41 kDa (monomer). The Recombinant Mouse TACI/TNFRSF13B Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Mouse TACI/TNFRSF13B Fc Chimera Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF13B, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B |
|---|
| Gene, Accession, CAS # | Tnfrsf13b, Gene ID: 57916, Accession: Q9ET35 |
|---|
| Catalog # | 1041-TC-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Mouse TACI/TNFRSF13B Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 20643338, 22961987, 24632732, 25505277 |
|---|
| 产品资料 |
|
|